UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 26,
Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Oramed Pharmaceuticals Charts.
Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals Inc. News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 17 September 2024 (22 hours ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 3 August 2024 (2 months ago) • Edgar (US Regulatory)
Oramed Letter to Shareholders
Wednesday 26 June 2024 (3 months ago) • PR Newswire (US)
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Wednesday 26 June 2024 (3 months ago) • PR Newswire (US)
Form ARS - Annual Report to Security Holders
Thursday 20 June 2024 (3 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Thursday 20 June 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 11 June 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 June 2024 (3 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 6 May 2024 (4 months ago) • Edgar (US Regulatory)
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Wednesday 20 March 2024 (6 months ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 7 March 2024 (6 months ago) • Edgar (US Regulatory)

More Oramed Pharmaceuticals Inc. News Articles